Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13717
Country/Region: Uganda
Year: 2017
Main Partner: Uganda Episcopal Conference
Main Partner Program: Registered Trustees
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: $574,741

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 74
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 151
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 538
GEND_GBV Number of people receiving post-GBV care 2018 763
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 59,236
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2018 12
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2018 42
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 9
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 5
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 10
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 2
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 27
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 8
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 136
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 195
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 16
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 27
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 57
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 165
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 109
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 271
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 109
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 271
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 57
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 57
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 4,492
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 5,240
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 4,492
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 751
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 23
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 78
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 16
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 10
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 40
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 7
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 117
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 34
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 640
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 819
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 65
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 103
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 40
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 138
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 29
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 17
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 377
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 54
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 1,168
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 247
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 5,038
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 6,177
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 506
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 760
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 17
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 136
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 29
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 17
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 304
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 58
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 949
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 244
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 4,820
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 4,856
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 480
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 601
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 126
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 3
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 6
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 17
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 95
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 87
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 10
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 11
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 2,813
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 3,283
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 2,813
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 470
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 40
HTS_TST Sum of Test Result disaggregates 2018 3,878
HTS_TST_POS By Test Result: Positive 2018 3,878
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 77
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 111
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 19
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 33
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 33
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 180
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 209
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 180
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 32
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 362
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 461
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 59
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 60
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 272
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 341
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 53
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 310
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 325
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 42
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 60
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 69
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 9
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 2,135
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 20
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 13
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 4
KP_PREV By key population type: Transgender who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 5
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 2,177
OVC_SERV Age/Sex: <1 2018 217
OVC_SERV Age/Sex: 1-9 2018 1,813
OVC_SERV Age/Sex: 10-14 Female 2018 716
OVC_SERV Age/Sex: 10-14 Male 2018 493
OVC_SERV Age/Sex: 15-17 Female 2018 381
OVC_SERV Age/Sex: 15-17 Male 2018 469
OVC_SERV By: Age/sex: 18-24 Female 2018 579
OVC_SERV By: Age/sex: 25+ Female 2018 164
OVC_SERV By: Age/sex: Male 18-24 2018 495
OVC_SERV By: Age/sex: Male 25+ 2018 114
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 5,441
OVC_SERV Program Completion: Active 2018 4,108
OVC_SERV Program Completion: Exited without graduation 2018 268
OVC_SERV Program Completion: Graduation 2018 789
OVC_SERV Program Completion: Transferred 2018 276
OVC_SERV Sum of Age/Sex disaggregates 2018 2,059
PMTCT_ART Already on ART at beginning of current pregnancy 2018 483
PMTCT_ART New on ART 2018 396
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 879
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 11,477
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 712
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 207
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 472
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 11
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 22
PMTCT_STAT By Age (Numerator): 10-14 2018 117
PMTCT_STAT By Age (Numerator): 15-19 2018 2,181
PMTCT_STAT By Age (Numerator): 20-24 2018 2,181
PMTCT_STAT By Age (Numerator): 25-49 2018 6,998
PMTCT_STAT By Number of known positives: 10-14 2018 9
PMTCT_STAT By Number of known positives: 15-19 2018 105
PMTCT_STAT By Number of known positives: 20-24 2018 184
PMTCT_STAT By Number of known positives: 25-49 2018 237
PMTCT_STAT By Number of new negative: 10-14 2018 109
PMTCT_STAT By Number of new negative: 15-19 2018 2,006
PMTCT_STAT By Number of new negative: 20-24 2018 1,869
PMTCT_STAT By Number of new negative: 25-49 2018 6,564
PMTCT_STAT By Number of new positives: 10-14 2018 4
PMTCT_STAT By Number of new positives: 15-19 2018 77
PMTCT_STAT By Number of new positives: 20-24 2018 135
PMTCT_STAT By Number of new positives: 25-49 2018 178
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 11,477
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,181
PMTCT_STAT_den By Age (Denominator): 10-14 2018 117
PMTCT_STAT_den By Age (Denominator): 20-24 2018 2,181
PMTCT_STAT_den By Age (Denominator): 25-49 2018 6,998
PP_PREV Age/sex: 10-14 Female 2018 1,248
PP_PREV Age/sex: 10-14 Male 2018 1,029
PP_PREV Age/sex: 15-19 Female 2018 672
PP_PREV Age/sex: 15-19 Male 2018 536
PP_PREV Age/sex: 20-24 Female 2018 478
PP_PREV Age/sex: 20-24 Male 2018 495
PP_PREV Age/sex: 25-49 Female 2018 1,479
PP_PREV Age/sex: 25-49 Male 2018 1,704
PP_PREV Age/sex: 50+ Female 2018 126
PP_PREV Age/sex: 50+ Male 2018 141
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 7,908
PP_PREV Sum of Age/Sex disaggregates 2018 7,908
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 13
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 109
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 15
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 186
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 339
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 323
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 14
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 113
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 16
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 196
TB_PREV By Age/Sex (Numerator): <15, Female 2018 16
TB_PREV By Age/Sex (Numerator): <15, Male 2018 15
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 771
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 638
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 1,440
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 1,440
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,874
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 31
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 26
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,542
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,275
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 2,874
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 23
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 229
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 32
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 401
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 685
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 685
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 23
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 229
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 32
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 401
TX_CURR Age/Sex: <1 2018 79
TX_CURR Age/Sex: <1-9 2018 1,239
TX_CURR Age/Sex: 10-14 Female 2018 397
TX_CURR Age/Sex: 10-14 Male 2018 281
TX_CURR Age/Sex: 15-19 Female 2018 721
TX_CURR Age/Sex: 15-19 Male 2018 164
TX_CURR Age/Sex: 20-24 Female 2018 2,282
TX_CURR Age/Sex: 20-24 Male 2018 695
TX_CURR Age/Sex: 25-49 Female 2018 16,343
TX_CURR Age/Sex: 25-49 Male 2018 10,068
TX_CURR Age/Sex: 50+ Female 2018 1,617
TX_CURR Age/Sex: 50+ Male 2018 1,245
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 35,131
TX_CURR Sum of age/sex disaggregates 2018 885
TX_NEW Breastfeeding status 2018 14
TX_NEW By Age/Sex: <1 2018 43
TX_NEW By Age/Sex: 1-9 2018 12
TX_NEW By Age/Sex: 10-14 Female 2018 3
TX_NEW By Age/Sex: 10-14 Male 2018 2
TX_NEW By Age/Sex: 15-19 Female 2018 74
TX_NEW By Age/Sex: 15-19 Male 2018 17
TX_NEW By Age/Sex: 20-24 Female 2018 230
TX_NEW By Age/Sex: 20-24 Male 2018 68
TX_NEW By Age/Sex: 25-49 Female 2018 1,298
TX_NEW By Age/Sex: 25-49 Male 2018 1,166
TX_NEW By Age/Sex: 50+ Female 2018 132
TX_NEW By Age/Sex: 50+ Male 2018 150
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,195
TX_NEW Pregnancy status 2018 802
TX_NEW Sum of Age/Sex disaggregates 2018 3,140
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 35,131
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 702
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 22
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 19
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 417
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 244
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,097
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 898
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 20,970
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 12,166
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,971
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 278
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 563
TX_TB_den Denominator: By Screen Result: Negative 2018 32,319
TX_TB_den Denominator: By Screen Result: Positive 2018 2,812
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 2,812
VMMC_CIRC By Age: 10-14 2018 817
VMMC_CIRC By Age: 15-19 2018 1,470
VMMC_CIRC By Age: 20-24 2018 1,959
VMMC_CIRC By Age: 25-29 2018 3,099
VMMC_CIRC By Age: 30-49 2018 490
VMMC_CIRC By Age: 50+ 2018 318
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 8,153
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 8,153
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 4,564